Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 77, 2022 - Issue 5
1,929
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Retrospective evaluation of routine whole genome sequencing of Mycobacterium tuberculosis at the Belgian National Reference Center, 2019

, ORCID Icon, , , , , ORCID Icon, , , & ORCID Icon show all

Figures & data

Figure 1. Comparison of the old (using conventional methods) and new (using WGS) diagnostic/surveillance strategies used in the Belgian NRC for M. tuberculosis complex. Turnaround time for the different steps is given. In case of urgent analysis, a GeneXpert® MTB/RIF assay can be performed

Tuberculosis PCR: Polymerase Chain reaction specific for Mycobacterium tuberculosis complex based on the detection of the 12.7-kb fragment [Citation16] MTB: Mycobacterium tuberculosis complex DST: Drug susceptibility Testing MIRU-VNTR: Mycobacterial Interspersed Repetitive Unit Variable Number Tandem Repeat
Figure 1. Comparison of the old (using conventional methods) and new (using WGS) diagnostic/surveillance strategies used in the Belgian NRC for M. tuberculosis complex. Turnaround time for the different steps is given. In case of urgent analysis, a GeneXpert® MTB/RIF assay can be performed

Table 1. Description of the phenotypic and genotypic drug resistance profiles obtained on the M. tuberculosis complex strains analysed in 2019 at the Belgian National Reference Center

Table 2. Performance of whole-genome sequencing compared to phenotypic drug susceptibility testing (MGIT) for first-line drugs on the M. tuberculosis complex strains analysed in 2019 at the Belgian National Reference Center

Supplemental material

Supplemental Material

Download MS Excel (908.4 KB)